CONSOLIDATED STATEMENTS OF EQUITY - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Treasury	Additional Paid-In Capital	Additional Paid-In Capital Cumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive Income (loss)	Accumulated Deficit	Accumulated Deficit Cumulative Effect, Period of Adoption, Adjustment
Beginning balance, shares (in shares) at Dec. 31, 2020			670,585,576
Beginning balance, shares (in shares) at Dec. 31, 2020				(549,907)
Beginning balance at Dec. 31, 2020	$ 1,671,551		$ 6,706	$ (1,791)	$ 3,152,694		$ (4,225)	$ (1,481,833)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Equity-based compensation expense	6,107				6,107
Exercise of common stock options and warrants (in shares)			181,125
Exercise of common stock options and warrants	467		$ 2		465
2025 convertible notes (in shares)			19,051,270	(8,105,175)
2025 convertible notes	55,275		$ 190		55,085
Net income (loss)	14,892							14,892
Other comprehensive income (loss)	(5,707)						(5,707)
Ending balance, shares (in shares) at Jun. 30, 2021			689,817,971
Ending balance, shares (in shares) at Jun. 30, 2021				(8,655,082)
Ending balance at Jun. 30, 2021	1,742,585		$ 6,898	$ (1,791)	3,214,351		(9,932)	(1,466,941)
Beginning balance, shares (in shares) at Dec. 31, 2020			670,585,576
Beginning balance, shares (in shares) at Dec. 31, 2020				(549,907)
Beginning balance at Dec. 31, 2020	1,671,551		$ 6,706	$ (1,791)	3,152,694		(4,225)	(1,481,833)
Ending balance, shares (in shares) at Dec. 31, 2021			690,082,283
Ending balance, shares (in shares) at Dec. 31, 2021				(8,655,082)
Ending balance at Dec. 31, 2021	$ 1,685,126	$ (21,642)	$ 6,901	$ (1,791)	3,222,487	$ (39,100)	(30,495)	(1,511,976)	$ 17,458
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accounting Standards Update [Extensible List]	Accounting Standards Update 2020-06
Beginning balance, shares (in shares) at Mar. 31, 2021			670,703,076
Beginning balance, shares (in shares) at Mar. 31, 2021				(549,907)
Beginning balance at Mar. 31, 2021	$ 1,696,514		$ 6,707	$ (1,791)	3,155,648		(13,295)	(1,450,755)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Equity-based compensation expense	3,460				3,460
Exercise of common stock options and warrants (in shares)			63,625
Exercise of common stock options and warrants	159		$ 1		158
2025 convertible notes (in shares)			19,051,270	(8,105,175)
2025 convertible notes	55,275		$ 190		55,085
Net income (loss)	(16,186)							(16,186)
Other comprehensive income (loss)	3,363						3,363
Ending balance, shares (in shares) at Jun. 30, 2021			689,817,971
Ending balance, shares (in shares) at Jun. 30, 2021				(8,655,082)
Ending balance at Jun. 30, 2021	1,742,585		$ 6,898	$ (1,791)	3,214,351		(9,932)	(1,466,941)
Beginning balance, shares (in shares) at Dec. 31, 2021			690,082,283
Beginning balance, shares (in shares) at Dec. 31, 2021				(8,655,082)
Beginning balance at Dec. 31, 2021	1,685,126	$ (21,642)	$ 6,901	$ (1,791)	3,222,487	$ (39,100)	(30,495)	(1,511,976)	$ 17,458
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Equity-based compensation expense	11,925				11,925
Exercise of common stock options and warrants (in shares)			602,087
Exercise of common stock options and warrants	(225)		$ 6		(231)
ModeX Acquisition (in shares)			89,907,311
ModeX Acquisition	219,374		$ 899		218,475
Net income (loss)	(157,083)							(157,083)
Other comprehensive income (loss)	$ (18,676)						(18,676)
Ending balance, shares (in shares) at Jun. 30, 2022			780,591,681
Ending balance, shares (in shares) at Jun. 30, 2022	(8,655,082)			(8,655,082)
Ending balance at Jun. 30, 2022	$ 1,718,799		$ 7,806	$ (1,791)	3,413,556		(49,171)	(1,651,601)
Beginning balance, shares (in shares) at Mar. 31, 2022			690,138,033
Beginning balance, shares (in shares) at Mar. 31, 2022				(8,655,082)
Beginning balance at Mar. 31, 2022	1,614,884		$ 6,901	$ (1,791)	3,191,139		(31,415)	(1,549,951)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Equity-based compensation expense	4,308				4,308
Exercise of common stock options and warrants (in shares)			546,337
Exercise of common stock options and warrants	(360)		$ 6		(366)
Net income (loss)	(101,650)							(101,650)
Other comprehensive income (loss)	$ (17,756)						(17,756)
Ending balance, shares (in shares) at Jun. 30, 2022			780,591,681
Ending balance, shares (in shares) at Jun. 30, 2022	(8,655,082)			(8,655,082)
Ending balance at Jun. 30, 2022	$ 1,718,799		$ 7,806	$ (1,791)	$ 3,413,556		$ (49,171)	$ (1,651,601)